University of Leicester
Browse

Body surface mapping of P-waves in sinus rhythm to predict recurrence following cardioversion for atrial fibrillation

Download (7.64 MB)
journal contribution
posted on 2025-09-18, 11:19 authored by Ibrahim Antoun, Xin LiXin Li, Ahmed Kotb, Joseph Barker, Akash Mavilakandy, Ivelin Koev, Zakariyya Vali, Riyaz Somani, Ghulam NgGhulam Ng
BackgroundDirect current cardioversion (DCCV) is used as elective and emergency rhythm control for atrial fibrillation (AF). We aimed to explore the role of P-wave parameters measured during sinus rhythm using body surface mapping (BSM) in predicting successful DCCV for persistent atrial fibrillation (persAF) at 12 months.MethodsThis case–control study included 56 males >18 years old who underwent DCCV for persAF. P-wave parameter collection after DCCV for AF was done using 128 unipolar leads. A band-pass filter of 1–50 Hz was utilised. Corrected P-wave duration (PWDc), P-wave amplitude, and P-wave dispersion were measured to predict 12-month outcomes and time of recurrence.ResultsThe mean age was 64 ± 4 years, and 23 patients (44%) were on amiodarone. The 12-month success rate was 44% (n = 23), while the rest reverted to AF after 2.6 ± 0.4 months. The parameters were comparable between successful and failed DCCV in the entire cohort and patients not on amiodarone. In patients on amiodarone, patients with failed arms had higher PWDc than those with successful arms (188 vs. 150 ms, P = 0.04). Receiver operator characteristic curve analysis for PWDc in the amiodarone cohort showed an area under the curve (AUC) of 0.75 and P = 0.049. A recurrence cut-off >161 ms had a sensitivity of 69% and a specificity of 100%, with a hazard ratio of 10.7, P = 0.004. The parameters were not predictive of the time of recurrence.ConclusionIn patients on amiodarone, increased PWDc measured using BSM was associated with higher AF recurrence at 12 months following DCCV for persAF.<p></p>

History

Author affiliation

College of Life Sciences College of Science & Engineering Medical Sciences Engineering

Version

  • VoR (Version of Record)

Published in

Frontiers in Cardiovascular Medicine

Volume

11

Pagination

1417029

Publisher

Frontiers Media SA

issn

2297-055X

eissn

2297-055X

Copyright date

2024

Available date

2025-09-18

Spatial coverage

Switzerland

Language

eng

Deposited by

Dr Ibrahim Antoun

Deposit date

2025-08-29

Data Access Statement

The raw data supporting the conclusions of this article will be made available by the authors without undue reservation.

Usage metrics

    University of Leicester Publications

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC